<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39319338</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2213-0071</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Respiratory medicine case reports</Title><ISOAbbreviation>Respir Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>Subacute thyroiditis after receiving the COVID-19 vaccine.</ArticleTitle><Pagination><StartPage>102096</StartPage><MedlinePgn>102096</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102096</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmcr.2024.102096</ELocationID><Abstract><AbstractText>Since the emergence of the coronavirus disease 2019 (COVID-19). Several autoimmune and subacute thyroiditis (SAT) cases are on the rise all over the world. COVID-19 vaccine-associated SAT cases have also been reported. In this article, we present our data on 5 vaccine-associated SAT cases. We evaluated the type of vaccine received, the time between vaccination and the onset of SAT symptoms, laboratory findings, treatments administered, and response to treatment. The age of patients ranged from 31 to 43 years old. Three (60 %) patients had been diagnosed as SAT after the first dose, and tow (40 %) after the second dose. Patients' symptoms appeared approximately 25.2 days (2-44) after vaccination. Subacute thyroiditis occurring after COVID-19 vaccination is rare, we hope practitioners should be early aware of post-vaccine SAT, that can improve clinical evolution and outcome.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yingshuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Jiangdu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med Case Rep</MedlineTA><NlmUniqueID>101604463</NlmUniqueID><ISSNLinking>2213-0071</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">Subacute thyroiditis</Keyword></KeywordList><CoiStatement>No conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319338</ArticleId><ArticleId IdType="pmc">PMC11419930</ArticleId><ArticleId IdType="doi">10.1016/j.rmcr.2024.102096</ArticleId><ArticleId IdType="pii">S2213-0071(24)00119-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zabidi N.Z., et al. Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies. Viruses. Apr 10 2023;15(4) doi: 10.3390/v15040944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040944</ArticleId><ArticleId IdType="pmc">PMC10145020</ArticleId><ArticleId IdType="pubmed">37112923</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L., Pitoia F., Esposito K., Piccardo A., Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev. Endocr. Metab. Disord. Dec 2021;22(4):803–815. doi: 10.1007/s11154-020-09615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09615-z</ArticleId><ArticleId IdType="pmc">PMC7688298</ArticleId><ArticleId IdType="pubmed">33241508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando Y., Ono Y., Sano A., Fujita N., Ono S. Subacute thyroiditis after COVID-19: a literature review. Am. J. Trop. Med. Hyg. Nov 14 2022;107(5):1074–1082. doi: 10.4269/ajtmh.21-1223.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-1223</ArticleId><ArticleId IdType="pmc">PMC9709026</ArticleId><ArticleId IdType="pubmed">36067987</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Resuli A., Bezgal M. Subacute thyroiditis in COVID-19 patients. Ear Nose Throat J. Sep 2022;101(8):501–505. doi: 10.1177/01455613211012114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211012114</ArticleId><ArticleId IdType="pubmed">33974811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozen M., et al. COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum. Vaccines Immunother. Dec 2 2021;17(12):5120–5125. doi: 10.1080/21645515.2021.2013083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.2013083</ArticleId><ArticleId IdType="pmc">PMC8904015</ArticleId><ArticleId IdType="pubmed">34893014</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M., Albizua-Madariaga I., Lertxundi U., Aguirre C. Subacute thyroiditis and COVID-19 vaccines: a case/non-case study. Endocrine. Sep 2022;77(3):480–485. doi: 10.1007/s12020-022-03101-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03101-z</ArticleId><ArticleId IdType="pmc">PMC9178315</ArticleId><ArticleId IdType="pubmed">35678975</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorulmaz G., Sahin Tekin M. SARS-CoV-2 vaccine-associated subacute thyroiditis. J. Endocrinol. Invest. Jul 2022;45(7):1341–1347. doi: 10.1007/s40618-022-01767-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01767-w</ArticleId><ArticleId IdType="pmc">PMC8857746</ArticleId><ArticleId IdType="pubmed">35182366</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyibo S.O. Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19) Cureus. Jun 2021;13(6) doi: 10.7759/cureus.16045.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.16045</ArticleId><ArticleId IdType="pmc">PMC8242270</ArticleId><ArticleId IdType="pubmed">34235030</ArticleId></ArticleIdList></Reference><Reference><Citation>Iremli B.G., Sendur S.N., Unluturk U. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J. Clin. Endocrinol. Metab. Aug 18 2021;106(9):2600–2605. doi: 10.1210/clinem/dgab373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab373</ArticleId><ArticleId IdType="pmc">PMC8194612</ArticleId><ArticleId IdType="pubmed">34043800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.S., Wheatley A.K., Kent S.J., DeKosky B.J. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. Oct 2020;5(10):1185–1191. doi: 10.1038/s41564-020-00789-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00789-5</ArticleId><ArticleId IdType="pubmed">32908214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney L.B., Stewart C., Gaitonde D.Y. Thyroiditis: an integrated approach. Am. Fam. Physician. Sep 15 2014;90(6):389–396. https://www.ncbi.nlm.nih.gov/pubmed/25251231 [Online]. Available.</Citation><ArticleIdList><ArticleId IdType="pubmed">25251231</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. Apr 2021;20(4) doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Latrofa F., Ricci D., Montanelli L., Altea M.A., Pucci A., Pinchera A., Vitti P. Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope. J. Endocrinol. Invest. Sep 2012;35(8):712–714. doi: 10.1007/BF03345804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03345804</ArticleId><ArticleId IdType="pubmed">23014133</ArticleId></ArticleIdList></Reference><Reference><Citation>Radenska-Lopovok S.G., Volkova P. [Autoimmune/inflammatory syndrome induced by adjuvants] Arkh. Patol. 2018;80(5):56–62. doi: 10.17116/patol20188005156. Autoimmunnyi/vospalitel'nyi sindrom, assotsiirovannyi s ad''iuvantami.</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/patol20188005156</ArticleId><ArticleId IdType="pubmed">30335063</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. Aug 2020;217 doi: 10.1016/j.clim.2020.108480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108480</ArticleId><ArticleId IdType="pmc">PMC7246018</ArticleId><ArticleId IdType="pubmed">32461193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito S., et al. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J. Endocrinol. Invest. Jun 2022;45(6):1189–1200. doi: 10.1007/s40618-022-01747-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01747-0</ArticleId><ArticleId IdType="pmc">PMC8800554</ArticleId><ArticleId IdType="pubmed">35094372</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J. Int. Med. Res. Feb 2022;50(2) doi: 10.1177/03000605221082898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605221082898</ArticleId><ArticleId IdType="pmc">PMC8894980</ArticleId><ArticleId IdType="pubmed">35226548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri R.M., Campenni A., Deandreis D., Siracusa M., Tozzoli R., Petranovic Ovcaricek P., Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expet Rev. Clin. Immunol. Jul 2021;17(7):737–759. doi: 10.1080/1744666X.2021.1932467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1932467</ArticleId><ArticleId IdType="pmc">PMC8182818</ArticleId><ArticleId IdType="pubmed">34015983</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>